BioBridgeXAll companies

CytoAgents, Inc.

Biotechnology company · Pittsburgh, Pennsylvania, United States

CytoAgents, Inc. is a biotechnology company headquartered in Pittsburgh, Pennsylvania, United States. Its earliest recorded incorporation is in 2018. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $7 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $7 million sold in a notice filed in 2023.

www.cytoagents.comProfile compiled from public records. Is this your company? Request a correction or update

CytoAgents at a glance

Typebiotechnology company
HeadquartersPittsburgh, Pennsylvania, United States
Earliest incorporation on record2018
Employees (self-reported, 2025)1
SEC CIK1877258

What does CytoAgents do?

US government research funding

4 SBIR/STTR small-business research awards from US health agencies, $7 million in total (2020 to 2025). NIH funding came from the National Institute of Allergy and Infectious Diseases, National Cancer Institute.

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $7 million sold (2023).

Frequently asked questions about CytoAgents

Where is CytoAgents headquartered?

CytoAgents, Inc. is headquartered in Pittsburgh, Pennsylvania, United States.

What does CytoAgents do?

CytoAgents, Inc. is a biotechnology company.

When was CytoAgents founded?

The earliest incorporation on record for CytoAgents, Inc. is in 2018, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-24. Data licences